Alembic Pharmaceuticals disclosed a good increase in consolidated net profit for the quarter ended September 2014. During the quarter, the profit of the company rose 25.36% to Rs 772.70 million from Rs 616.40 million in the same quarter last year.
Net sales for the quarter rose 12.48% to Rs 5,470.80 million, compared with Rs 4,864 million for the prior year period.
Earnings per share for the quarter stood at Rs 4.10, registering 25.38% growth over previous year period.
Quarterly Results - consolidated (Rs in mn) |
As at | Sep - 14 | Sep - 13 | %Change |
Net Sales | 5,470.80 | 4,863.60 | 12.48 |
Net Profit | 772.70 | 616.40 | 25.36 |
Basic EPS | 4.10 | 3.27 | 25.38 |
Shares of the company gained Rs 22.6, or 5.84%, to trade at Rs 409.45. The total volume of shares traded was 83,701 at the BSE (1.41 p.m., Monday).